We are live on
!
Find out more
AI
Atom Investors Portfolio holdings
AUM
$1.4B
1-Year Est. Return
23.77%
This Fund
S&P 500
This Quarter
Est. Return
+8.36%
1 Year Est. Return
+23.77%
3 Year Est. Return
+63.44%
5 Year Est. Return
+52.26%
10 Year Est. Return
–
AUM
$200M
AUM Growth
-$84.2M
(-30%)
Cap. Flow
-$93.6M
Cap. Flow
% of AUM
-46.8%
Top 10 Holdings %
Top 10 Hldgs %
34.61%
Holding
366
New
92
Increased
36
Reduced
84
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$4.41M |
| 2 |
Costco
COST
|
+$3.15M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$3.05M |
| 4 |
Walmart Inc
WMT
|
+$2.94M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$2.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$10M |
| 2 |
Walt Disney
DIS
|
+$4.7M |
| 3 |
GLHA
Glass Houses Acquisition Corp. Class A common stock
GLHA
|
+$4.48M |
| 4 |
T-Mobile US
TMUS
|
+$4.41M |
| 5 |
State Street SPDR S&P Retail ETF
XRT
|
+$3.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.39% |
| 2 | Real Estate | 10.52% |
| 3 | Healthcare | 9.33% |
| 4 | Technology | 7.73% |
| 5 | Industrials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
ProQR Therapeutics
PRQR
$243M
| $68.5K | 0.03% |
18,522
-10,299
| -36% | -$13.5K |
|
|
KBAL
202
DELISTED
Kimball International
KBAL
| $68K | 0.03% |
10,464
-2,862
| -21% | -$19.6K |
|
203
Praxis Precision Medicines
PRAX
$8.58B
| $63.3K | 0.03% |
+1,773
| New | +$55.3K |
|
204
Clover Health Investments
CLOV
$2.2B
| $61.8K | 0.03% |
+66,482
| New | +$88.7K |
|
|
GPGI
205
GPGI Inc
GPGI
$3.83B
| $61K | 0.03% |
14,961
-7,312
| -33% | -$30.4K |
|
206
Aurora
AUR
$12.6B
| $59.7K | 0.03% |
49,338
+6,867
| +16% | +$11.7K |
|
207
Trevi Therapeutics
TRVI
$2.59B
| $49K | 0.02% |
+25,376
| New | +$50K |
|
|
USBC
208
USBC Inc
USBC
$125M
| $37.5K | 0.02% |
+586
| New | +$36.6K |
|
|
NUTX
209
Nutex Health
NUTX
$1.01B
| $31K | 0.02% |
+109
| New | +$20.9K |
|
210
Gossamer Bio
GOSS
$82.9M
| $27.8K | 0.01% |
+12,808
| New | +$105K |
|
211
Cardiff Oncology
CRDF
$66.5M
| $25.6K | 0.01% |
18,298
| – | – |
|
212
PUT
United States Oil Fund
USO
$2.15B
| $25.2K | 0.01% |
+33,000
| New | +$2.31M |
|
|
AEVA
213
Aeva Technologies
AEVA
$1.2B
| $25.1K | 0.01% |
3,694
-2,149
| -37% | -$18.8K |
|
214
BARK
BARK
$81.8M
| $23.9K | 0.01% |
803
-659
| -45% | -$21.9K |
|
215
Outdoor Holding Co
POWW
$249M
| $18.9K | 0.01% |
10,948
-9
| -0.1% | -$23 |
|
|
SHCR
216
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $16.4K | 0.01% |
+10,258
| New | +$19K |
|
|
VXRT
217
DELISTED
Vaxart
VXRT
| $13.6K | 0.01% |
14,121
-3,636
| -20% | -$5.14K |
|
218
Adtran
ADTN
$689M
| – | – |
-90,453
| Closed | -$1.77M |
|
219
Aehr Test Systems
AEHR
$2.61B
| – | – |
-45,492
| Closed | -$641K |
|
220
C3.ai
AI
$1.43B
| – | – |
-16,332
| Closed | -$204K |
|
|
ALE
221
DELISTED
Allete
ALE
| – | – |
-29,809
| Closed | -$1.49M |
|
222
Altimmune
ALT
$552M
| – | – |
-26,818
| Closed | -$342K |
|
223
Antero Midstream
AM
$10.4B
| – | – |
-18,261
| Closed | -$168K |
|
224
Abercrombie & Fitch
ANF
$4.42B
| – | – |
-82,488
| Closed | -$1.28M |
|
225
Avery Dennison
AVY
$13B
| – | – |
-3,892
| Closed | -$633K |
|
Similar funds
SP
ELC
HRES
SRAIM
PMG
TCC
FCP
SC
Atom Investors's Q4 2022 Portfolio in Review
As of Q4 2022, Atom Investors held 366 positions worth $200M, down 30% from $284M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Atom Investors withdrew a net $93.6M in Q4 2022, closing 149 positions and reducing 84 holdings. Its most notable exit was Glass Houses Acquisition Corp. Class A common stock, an estimated $4.48M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Atom Investors opened a new position in Costco worth $2.94M.
- Atom Investors's largest Q4 2022 buy was Costco: 6,443 shares worth $2.94M.
- Atom Investors added most to State Street SPDR S&P Biotech ETF in Q4 2022, an estimated $4.41M increase.
- Atom Investors's biggest Q4 2022 reduction was Microsoft, cutting an estimated $10M.
- Atom Investors fully exited Glass Houses Acquisition Corp. Class A common stock in Q4 2022, selling an estimated $4.48M.
- Atom Investors's ten largest holdings make up 35% of its $200M portfolio in Q4 2022.
- Atom Investors opened 92 new positions and closed 149 in Q4 2022.
- Atom Investors's portfolio value fell 30% quarter-over-quarter to $200M.
Based on Atom Investors's 13F filing for Q4 2022, filed 14 Feb 2023.